Vitalis is a leading manufacturer and wholesaler of injectable pharmaceutical products in Colombia and Mexico.

Vitalis是哥伦比亚和墨西哥领先的注射剂药品制造商和批发商。

WASHINGTON, Jan. 18, 2024 /PRNewswire/ -- ACON Investments ('ACON'), a private equity investment firm based in Washington, D.C., announced today a definitive agreement to sell Vitalis to Mexican multinational Laboratorios Sanfer.

华盛顿，2024年1月18日/PRNewswire/--总部位于华盛顿特区的私人股本投资公司ACON Investments（“ACON”）今天宣布了一项最终协议，将Vitalis出售给墨西哥跨国实验室疗养院（Laboratorios Sanfer）。

Vitalis is a Colombia-based manufacturer and wholesaler of injectable products used in hospitals, medical institutions and pharmacies across Latin America. The company has over 700 individual product registrations in more than 20 therapeutical areas, and a 45-year track record.

Vitalis是一家总部位于哥伦比亚的可注射产品制造商和批发商，用于拉丁美洲的医院、医疗机构和药房。该公司在20多个治疗领域拥有700多个个人产品注册，并有45年的业绩记录。

'The team at Vitalis is enthusiastic to begin this new era of growth, consolidating its position as a key player in the Latin American pharmaceutical market. We are confident that Sanfer's experience, know-how and leadership will exponentially boost the company's growth and expansion plans,' commented Alberto Hernandez, Partner at ACON..

维塔利斯的团队热衷于开启这一新的增长时代，巩固其在拉丁美洲制药市场的关键地位。ACON合伙人阿尔贝托·埃尔南德斯（AlbertoHernandez）评论道：“我们相信，桑弗（Sanfer）的经验、专有技术和领导力将成倍推动公司的增长和扩张计划。”。。

Jose Miguel Knoell, Managing Partner at ACON, stated, 'ACON, together with a group of co-investors, acquired 100% of Vitalis in May 2021. During ACON's investment, and thanks to the great effort of the Vitalis team, the company rapidly increased sales and profitability as it opened new commercial channels, upgraded all of its manufacturing facilities across Colombia, Mexico and Chile, made important investments in quality control and safety, and implemented industry-leading environmental, social and governance standards.'.

ACON管理合伙人何塞·米格尔·克诺尔（JoseMiguelKnoell）表示，“ACON与一群共同投资者于2021年5月收购了维塔利斯100%的股份。在ACON投资期间，由于Vitalis团队的努力，该公司迅速提高了销售额和盈利能力，开辟了新的商业渠道，升级了哥伦比亚、墨西哥和智利的所有制造设施，在质量控制和安全方面进行了重要投资，并实施了业界领先的环境、社会和治理标准。”。

Mr. Knoell continued, 'Our investment in Vitalis is a clear example of ACON's reach across Latin America and our continued efforts to promote investments with high social impact and positive outcomes for all stakeholders: Vitalis will continue its mission of supplying high-quality, efficient and secure pharmaceutical products across Latin America, maintaining a focus on patients.'.

克诺尔先生继续说道，“我们对维他利斯的投资是ACON在拉丁美洲影响力的一个明显例子，也是我们继续努力促进投资，为所有利益相关者带来高社会影响和积极成果的一个明显例子：维他利斯将继续在整个拉丁美洲提供优质，高效和安全的药品，保持对患者的关注。”。

The transaction is subject to approval by the Colombian and Mexican antitrust authorities and other conditions customary for this type of transaction. Financial terms of the transaction were not disclosed.

该交易须经哥伦比亚和墨西哥反托拉斯机构批准，以及此类交易的其他惯常条件。交易的财务条款没有披露。

ACON is an active investor in the Latin American region. At closing, Vitalis will be the first exit of ACON's fifth regional investment fund. Additionally, this will be ACON's third divestment across its Latin America platform in the last 24 months. Over the past 27 years, the firm has made 41 investments in 10 countries, and exited 30 investments in total..

ACON是拉丁美洲地区的积极投资者。收盘时，维塔利斯将是ACON第五个区域投资基金的首次退出。此外，这将是ACON在过去24个月内对其拉丁美洲平台的第三次撤资。在过去的27年中，该公司在10个国家进行了41项投资，总共退出了30项投资。。

About Laboratorios Sanfer:

关于Sanfer实验室：

Laboratorios Sanfer is the third largest pharmaceutical company in Mexico with over 80 years of experience in the market. In parallel, Sanfer has acquired companies and commercial brands across Latin America, growing its international business to 40% of its revenues. The company has over 10,000 employees and a presence across 30 countries in Latin America (except Brazil), with subsidiaries in Colombia, Argentina, Peru (where it is the largest pharmaceutical laboratory in terms of units), and Chile.

Laboratorios Sanfer是墨西哥第三大制药公司，拥有80多年的市场经验。与此同时，桑菲尔收购了整个拉丁美洲的公司和商业品牌，将其国际业务增长至其收入的40%。该公司拥有10000多名员工，业务遍及拉丁美洲（巴西除外）的30个国家，在哥伦比亚、阿根廷、秘鲁（按单位计它是最大的制药实验室）和智利设有子公司。

The Company also holds offices and distribution centers in Ecuador, serving Bolivia, Uruguay, and Paraguay, and in Panama, serving the Central American and Caribbean markets. For more information, visit https://www.sanfer.com.mx..

该公司还在厄瓜多尔（服务于玻利维亚、乌拉圭和巴拉圭）和巴拿马（服务于中美洲和加勒比市场）设有办事处和配送中心。有关更多信息，请访问https://www.sanfer.com.mx..

About Vitalis:

关于Vitalis：

Vitalis is one of the most respected manufacturers and wholesalers of generic injectable pharmaceuticals in the industry. Through its renowned safe labeling and packaging, Vitalis has increased the industry's safety practices by helping prevent human error in administering pharmaceutical products and improving product traceability.

Vitalis是业内最受尊敬的仿制药生产商和批发商之一。通过其著名的安全标签和包装，Vitalis通过帮助防止药品管理中的人为错误和改进产品可追溯性，提高了行业的安全实践。

Its portfolio of over 700 individual product registrations covers over 20 therapeutical areas, standing out in areas such as antibiotics, anesthetics, analgesics, and corticosteroids. Vitalis manufactures its products in its facilities in Colombia, Mexico, and Chile and sells to over 20 countries. For more information, visit https://www.vitalislaboratorio.com..

它拥有700多个个人产品注册组合，涵盖20多个治疗领域，在抗生素、麻醉药、止痛药和皮质类固醇等领域脱颖而出。Vitalis在哥伦比亚、墨西哥和智利的工厂生产产品，并销往20多个国家。有关更多信息，请访问https://www.vitalislaboratorio.com..

About ACON Investments:

关于ACON投资：

ACON Investments, L.L.C. is a Washington, D.C.-based international private equity investment firm that manages private equity funds and special purpose partnerships that make investments in the United States, Latin America and Europe. With professionals in Washington, D.C., Dallas, Los Angeles, New York, Bogotá, Madrid, Mexico City and São Paulo, ACON has managed $7.0 billion in assets since inception and has a 28-year track record.

ACON Investments，L.L.C.是一家总部位于华盛顿特区的国际私人股本投资公司，管理私人股本基金和在美国、拉丁美洲和欧洲进行投资的特殊目的合伙企业。ACON拥有华盛顿特区、达拉斯、洛杉矶、纽约、波哥大、马德里、墨西哥城和圣保罗的专业人员，自成立以来管理着70亿美元的资产，拥有28年的业绩记录。

For more information, visit www.aconinvestments.com..

有关更多信息，请访问www.aconinvestments.com。。

Contact

联系人

Meena TheverACON Investments, L.L.C.[email protected] | 202.454.1100

Meena TheverACON Investments，L.L.C.[受电子邮件保护]| 202.454.1100

SOURCE ACON Investments, L.L.C.

资料来源：ACON投资有限公司。